Quest Diagnostics, Inc.
NYSE:DGX 3:59:57 PM EDT
Other Pre-Announcement
Quest Diagnostics Reports Q4 And Full Year 2022 Financial Results
Published: 02/02/2023 13:10 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Guidance for Full Year 2023.
Sees 2023 Covid-19 Testing Revenues $175 Million- $275 Million.
Sees 2023 Capital Expenditures Approximately $400 Million.
Sees 2023 Net Revenue Between $8.83 Billion - $9.03 Billion.
FY2023 Revenue View $9.13 Billion -- Refinitiv Ibes Data (analyst estimates).
Sees 2023 Covid-19 Testing Revenues $175 Million- $275 Million.
Sees 2023 Capital Expenditures Approximately $400 Million.
Sees 2023 Net Revenue Between $8.83 Billion - $9.03 Billion.
FY2023 Revenue View $9.13 Billion -- Refinitiv Ibes Data (analyst estimates).